Find uplifting stories about heroes, innovations, and solutions
18738 results for "pancreatic cancer research"
Scientists at Baylor College of Medicine are advancing treatments for pancreatic cancer, one of the most lethal forms of the disease. New research offers hope for patients facing this challenging diagnosis.
Scientists in Ireland have created the first complete "playbook" of pancreatic cancer, revealing why it's been so deadly and where new treatments could finally work. Their breakthrough approach targets multiple weak points at once, offering fresh hope for a disease that has resisted progress for decades.
A new pill targeting the KRAS mutation doubles survival time in pancreatic cancer patients, marking the biggest treatment breakthrough ever for one of the world's deadliest cancers. After 25 years of research and $17 million in funding, scientists are finally seeing progress on multiple fronts at once.
A reluctant 18-year-old attended one Relay For Life event and found his calling. Today, Cody Wolf is an American Cancer Society-funded researcher developing new treatments for pancreatic cancer. #
Researchers discovered that pancreatic cancer cells depend on inflammation from damaged mitochondria to survive, and blocking this process kills tumors. The breakthrough could finally offer new treatment options for one of the deadliest cancers.
Scientists at Oregon Health & Science University just cracked a puzzle that's stumped cancer researchers for years: why pancreatic cancer fights off immunotherapy. The discovery could finally give patients new treatment options.
University of Pennsylvania researchers eliminated precancerous pancreatic cells in mice before they became tumors, nearly doubling survival time. It's the first proof that medical intervention can stop pancreatic cancer at its earliest stage.
Researchers at the University of Miami have discovered how to break down one of pancreatic cancer's strongest defenses, opening the door to a groundbreaking clinical trial. Their work earned a prestigious $800,000 grant and could transform treatment for one of medicine's deadliest cancers.
A new vaccine prevented pancreatic cancer from developing in 20 high-risk patients, with 90% showing lasting immune responses. For the first time, researchers have found a way to intercept one of the deadliest cancers before it starts.
Researchers at UCLA have developed a once-daily pill that targets a protein crucial to pancreatic cancer growth, offering new hope for one of the deadliest cancers. The breakthrough treatment represents a major step forward in fighting a disease that has long resisted effective therapies.
Spanish researchers have eliminated pancreatic cancer in mice using an innovative triple therapy approach. The breakthrough offers new hope for treating one of the deadliest forms of cancer.
Scientists in Spain eliminated pancreatic tumors in mice using a triple-drug therapy, with no cancer returning over 200 days. The breakthrough targets the deadliest form of pancreatic cancer and could reshape treatment if human trials succeed.
A leukemia survivor and a researcher who beat cancer are driving groundbreaking pediatric cancer research at Purdue University, inspired by beloved student Tyler Trent. Their work focuses on making treatments safer and more effective for kids fighting cancer.
A breakthrough drug for pancreatic cancer has stunned researchers by controlling disease in 90% of patients who had already tried chemotherapy. The daily pill targets gene mutations found in nearly all pancreatic cancers, offering hope where treatment options have been scarce.
Researchers in Spain have completely eliminated pancreatic tumors in mice using a groundbreaking triple-drug therapy with no major side effects. The discovery brings fresh hope for treating one of the deadliest cancers, with human clinical trials potentially on the horizon.
Brazilian researchers discovered how pancreatic cancer uses a protein called periostin to invade nerves and spread throughout the body. This breakthrough could lead to new treatments that stop the disease before it becomes deadly.
A breakthrough drug targeting previously "undruggable" KRAS mutations has approximately doubled survival time for metastatic pancreatic cancer patients compared to chemotherapy. The development marks a historic shift for a disease that affects over 90% of pancreatic cancer cases. --- ##
Researchers at Duke-NUS Medical School discovered how to flip pancreatic cancer cells from treatment-resistant back to treatable by targeting the genetic pathway that shuts down a key protective gene. The breakthrough could help doctors make some of the deadliest tumors respond to chemotherapy again.
A Danish research team has developed a breakthrough therapy for pancreatic cancer, one of the deadliest forms of the disease. Their work shows how university scientists are solving problems Big Pharma won't touch.
Researchers at MD Anderson Cancer Center discovered a protein called DPY30 that helps pancreatic tumors hide from the immune system. Blocking this protein could make stubborn tumors respond to immunotherapy, offering fresh hope for patients with limited treatment options.
Showing 20 of 18738